-
ISIN | US21077P1084 |
---|---|
Exchange | NASDAQ |
CurrencyCode | USD |
Sector | Healthcare |
Industry | Biotechnology |
Beta | 2.18 |
---|---|
Market Cap | 85M |
PE Ratio | None |
Target Price | 6.6 |
Dividend Yield | None |
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CNTX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025